Phase III trials of a COVID-19 vaccine developed by China's Sinovac Biotech Ltd have thus far demonstrated promising results, with the vaccine potentially available commercially by December. According to Sao Paulo’s Governor Joao Doria, 98 percent of elderly people dosed generated an immune response. Approximately 9,000 people are participating in the trial. Yourway has a local depot located in Sao Paulo with over 10,000 square feet of capacity with storage temperatures of up to -20 degrees Celsius.